In diabetic nephropathy (DN), NLRP3 inflammasomes promoted disease onset and progress under high-glucose conditions [86]; meanwhile, IL-1β and IL-18 secreted from both immune cells and glomerular resident cells exaggerated disease severity [87–89]. The gene discussed is NLRP3; the disease is liver dysplastic nodule.